Homepage

Investing
in life.

Making
an impact.

Working
together.

Investing
in life.

Making
an impact.

Working
together.

Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.

Azafaros, a clinical-stage company focused on developing disease-modifying therapeutics to offer new treatment options to patients with rare lysosomal storage disorders, announces the completion of an oversubscribed €132M Series B financing led by Jeito Capital, co-led by Forbion Growth and additional participation from Seroba, Pictet Group and existing investors Forbion Ventures, Schroders Capital and BioGeneration Ventures (BGV) . This financing …

  • Therapeutics
Explore

TEPYLUTE 100mg is the first multi-dose formulation of thiotepa that is stable for 14 days when properly stored. TEPYLUTE is Shorla Oncology’s fourth launch in the U.S. Market. CAMBRIDGE, Mass.–(BUSINESS WIRE)–Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted approval for 100 mg/10mL multi-dose vial of TEPYLUTE, a ready-to-dilute formulation …

  • Therapeutics
Explore

Perfuze, a leader in next-generation catheter-based technology for the treatment of acute ischemic stroke, today announced two significant milestones in its mission to improve stroke care: 1) the completion of patient enrollment in its U.S. pivotal IDE clinical trial, MARRS (Millipede Aspiration for Revascularization in Stroke Study), and 2) the appointment of seasoned medtech executive Joe Rotger as Executive Vice …

  • Medtech
Explore
Discover all news

Complementary skill sets with deep investment and operational industry experience. Seroba helps entrepreneurs create and build world class businesses around extraordinary science.

  • Venture partner

Jeanne Bolger
  • Accountant

Anita Dipalo
  • CFO
  • Partner

Andrew Duignan
  • Operations Manager

Ciara Green
  • Investment Analyst

Sophie Hughes
  • Investor relations
  • Partner

Maud Lazare
  • Partner

Jennifer McMahon
  • Partner

Bruno Montanari
  • Partner

Alan O’Connell
  • Partner

Daniel O’Mahony
  • Partner

Catello Somma

A Portfolio of
Outstanding Companies
Discover full portfolio
Subscribe to our Newsletter
* = required field